GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » EV-to-EBITDA

Bluemtec Co (XKRX:439580) EV-to-EBITDA : 105.39 (As of May. 28, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bluemtec Co's enterprise value is ₩135,030 Mil. Bluemtec Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,281 Mil. Therefore, Bluemtec Co's EV-to-EBITDA for today is 105.39.

The historical rank and industry rank for Bluemtec Co's EV-to-EBITDA or its related term are showing as below:

XKRX:439580' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.72   Med: -11.08   Max: 114.54
Current: 105.38

During the past 3 years, the highest EV-to-EBITDA of Bluemtec Co was 114.54. The lowest was -23.72. And the median was -11.08.

XKRX:439580's EV-to-EBITDA is ranked worse than
95.91% of 465 companies
in the Healthcare Providers & Services industry
Industry Median: 12.65 vs XKRX:439580: 105.38

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-28), Bluemtec Co's stock price is ₩12720.00. Bluemtec Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-456.003. Therefore, Bluemtec Co's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bluemtec Co EV-to-EBITDA Historical Data

The historical data trend for Bluemtec Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co EV-to-EBITDA Chart

Bluemtec Co Annual Data
Trend Dec20 Dec21 Dec22
EV-to-EBITDA
- - -

Bluemtec Co Quarterly Data
Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial - - - -160.11 118.45

Competitive Comparison of Bluemtec Co's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Bluemtec Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bluemtec Co's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bluemtec Co's EV-to-EBITDA falls into.



Bluemtec Co EV-to-EBITDA Calculation

Bluemtec Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=135029.962/1281.247
=105.39

Bluemtec Co's current Enterprise Value is ₩135,030 Mil.
Bluemtec Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,281 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bluemtec Co  (XKRX:439580) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bluemtec Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=12720.00/-456.003
=At Loss

Bluemtec Co's share price for today is ₩12720.00.
Bluemtec Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-456.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bluemtec Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bluemtec Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bluemtec Co (XKRX:439580) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 322-2, 322-2A, 184, Jungbu-daero, Giheung-gu , Gyeonggi-do, 1612, 1613, 1614, 1615 Yeongdeok-dong, Hicks U Tower, Yongin-si, KOR
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, they are operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co (XKRX:439580) Headlines

No Headlines